Awakn Life Sciences Corp. — Form D
Awakn Life Sciences Corp. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-21. The offering totals $3.0M, of which $1.4M was reported sold. Industry: Other.
Offering
- Filed: 2022-11-21
- Form: D
- Accession: 0001062993-22-022575
- Industry: Other
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.4M
- Remaining: $1.6M
- Investors: 9
- Date of first sale: 2022-11-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-465509
Issuer
- Name: Awakn Life Sciences Corp.
- CIK: 0001948724
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2018
- Address: 301-217 QUEEN ST WEST, TORONTO, A6, M5V 0R2
- Phone: 416-270-9566
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jonathan Held | Director | Toronto, A6 |
| Benjamin Sessa | Executive Officer | Toronto, A6 |
| George Scorsis | Director | GAITHERSBURG, MD |
| James Collins | Executive Officer | Cambridge, MA |
| Shaun McNulty | Executive Officer | Toronto, A6 |
| Jonathan Held | Executive Officer | Toronto, A6 |
| Steve Page | Director | Red Bank, NJ |
| John Papastergiou | Director | Toronto, A6 |
| Paul Carter | Director | Toronto, A6 |
| Anthony Tennyson | Director | Toronto, A6 |
| Anthony Tennyson | Executive Officer | Toronto, A6 |
| Benjamin Sessa | Director | Toronto, A6 |
Other filings by this issuer (3)
More